FTAA could interfere with proposed Canadian patent legislation allowing generic exports
AUTOR(ES)
Silversides, Ann
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=359417Documentos Relacionados
- Amended patent legislation still flawed
- Guardians at the gate: Biosimilar and patent reform legislation could fundamentally change the guards for therapeutic monoclonal antibodies—Part 2
- Canadian legislation regarding venereal disease
- Dying while living: a critique of allowing-to-die legislation.
- Drug patent expirations and the speed of generic entry.